Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
You can purchase shares of Cidara Therapeutics (NASDAQ:CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX), Monopar Therapeutics (NASDAQ:MNPR) and Inovio Pharmaceuticals (NASDAQ:INO).
Cidara Therapeutics has a consensus price target of $30.50.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $14.5 last updated November 18, 2024 at 8:44 AM EST.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Cidara Therapeutics.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.